98 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 2 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x RNA TS TPMi x
ADORA1Adenosine A1 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Plasma membraneTissue enhancedcerebral cortex:50.2
testis:25.4
ADORA2AAdenosine A2a receptorCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhancedbone marrow:24.6
lymph node:22.7
ADORA2BAdenosine A2b receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
CytosolMixed
ADORA3Adenosine A3 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
ADRA1AAdrenoceptor alpha 1AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhancedadipose tissue:22.6
liver:31.6
prostate:20.8
ADRA1BAdrenoceptor alpha 1BCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Plasma membraneTissue enhancedcerebral cortex:14.8
spleen:17.0
ADRA1DAdrenoceptor alpha 1DFDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhancedcervix, uterine:4.3
prostate:4.5
ADRA2AAdrenoceptor alpha 2AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
ADRA2CAdrenoceptor alpha 2CFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhancedcervix, uterine:20.9
endometrium:26.0
seminal vesicle:26.8
ADRB1Adrenoceptor beta 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhancedplacenta:45.4
ADRB2Adrenoceptor beta 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
CytosolMixed
ADRB3Adrenoceptor beta 3FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhancedovary:8.9
placenta:3.7
AGTR1Angiotensin II receptor type 1Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
VesiclesTissue enhancedplacenta:214.0
AVPR1AArginine vasopressin receptor 1AFDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhancedadrenal gland:77.8
AVPR1BArginine vasopressin receptor 1BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Not detected
AVPR2Arginine vasopressin receptor 2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhancedadipose tissue:5.8
BDKRB2Bradykinin receptor B2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
CASRCalcium sensing receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enrichedparathyroid gland:1441.4
CCKARCholecystokinin A receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enrichedgallbladder:47.2
stomach:15.2
CCKBRCholecystokinin B receptorCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedcerebral cortex:13.6
pancreas:5.4
stomach:16.4
CCR5C-C motif chemokine receptor 5 (gene/pseudogene)CD markers
Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
CHRM1Cholinergic receptor muscarinic 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Nucleus
Cytosol
Group enrichedcerebral cortex:39.9
prostate:42.3
salivary gland:11.0
CHRM2Cholinergic receptor muscarinic 2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhancedgallbladder:18.3
heart muscle:25.8
smooth muscle:13.7
CHRM3Cholinergic receptor muscarinic 3Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Plasma membraneTissue enhancedcerebral cortex:15.7
CHRM4Cholinergic receptor muscarinic 4FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Nucleus
Golgi apparatus
Tissue enhancedcerebral cortex:8.1
small intestine:7.8
spleen:21.4
CHRM5Cholinergic receptor muscarinic 5FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhancedcerebral cortex:3.1
testis:3.4
CNR1Cannabinoid receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhancedcerebral cortex:32.1
CNR2Cannabinoid receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Group enrichedappendix:3.1
lymph node:8.7
spleen:7.9
tonsil:6.9
CRHR1Corticotropin releasing hormone receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enhancedcerebral cortex:4.0
CXCR4C-X-C motif chemokine receptor 4Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhancedbone marrow:771.6
CYSLTR1Cysteinyl leukotriene receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Mixed
CYSLTR2Cysteinyl leukotriene receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhancedplacenta:36.7
seminal vesicle:25.0
DRD1Dopamine receptor D1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhancedcerebral cortex:8.0
DRD2Dopamine receptor D2FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhancedadrenal gland:11.2
DRD3Dopamine receptor D3Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enrichedtestis:1.3
DRD4Dopamine receptor D4FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Not detected
DRD5Dopamine receptor D5Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhancedappendix:1.7
cerebral cortex:2.0
stomach:3.8
EDNRAEndothelin receptor type ADisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhancedseminal vesicle:146.8
EDNRBEndothelin receptor type BDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Tissue enhancedplacenta:180.2
F2RCoagulation factor II thrombin receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
FFAR1Free fatty acid receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhancedbone marrow:1.9
FSHRFollicle stimulating hormone receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Transporters
Group enrichedovary:2.5
testis:4.3
GABBR1Gamma-aminobutyric acid type B receptor subunit 1FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
CentrosomeTissue enhancedcerebral cortex:20.8
GABBR2Gamma-aminobutyric acid type B receptor subunit 2FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enrichedcerebral cortex:77.9
GCGRGlucagon receptorFDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatusGroup enrichedadrenal gland:6.6
kidney:8.4
liver:20.8
parathyroid gland:8.0
GHRHRGrowth hormone releasing hormone receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Not detected
GLP1RGlucagon like peptide 1 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhancedcerebral cortex:1.9
heart muscle:1.8
GLP2RGlucagon like peptide 2 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Plasma membraneTissue enhancedgallbladder:19.3
GNRHRGonadotropin releasing hormone receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhancedadrenal gland:1.0
GRM5Glutamate metabotropic receptor 5FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enrichedcerebral cortex:27.2
Page of 2 | next »